Boston Scientific (NYSE:BSX), founded in 1979 and headquartered in Marlborough, Massachusetts, is a global developer, manufacturer, and marketer of medical devices designed to diagnose and treat a broad range of cardiovascular, respiratory, digestive and urological conditions. Over more than four decades, the company has built a reputation for innovation in minimally invasive therapies, enabling physicians and healthcare providers to deliver advanced care to patients around the world.
The company’s core product portfolio spans interventional cardiology, electrophysiology, peripheral interventions, endoscopy, urology and neuromodulation. In cardiovascular care, Boston Scientific offers drug-eluting stents, pacemakers and implantable cardioverter-defibrillators, along with diagnostic catheters and balloons for angioplasty. Its endoscopy range includes advanced imaging systems and biopsy tools for gastrointestinal procedures, while urology products feature lithotripsy devices and implantable stents for the treatment of urinary strictures. The neuromodulation business provides spinal cord stimulation systems for chronic pain management, as well as implants for movement and pelvic health disorders.
With operations in more than 130 countries, Boston Scientific serves hospitals, outpatient clinics and physician offices across the Americas, Europe, the Middle East, Africa and the Asia-Pacific region. The company maintains research and development centers in North America and Europe, with additional manufacturing facilities in Ireland, Costa Rica and India. This global footprint supports collaboration with leading clinicians and academic institutions to advance clinical research and product innovation.
Leadership at Boston Scientific is headed by President and Chief Executive Officer Robert S. Ford, who brings extensive industry experience and a focus on strategic growth and operational excellence. The company’s commitment to cutting-edge technology is evidenced by a series of strategic acquisitions over the years, which have expanded its therapeutic offerings and strengthened its position in key markets. Through continual investment in R&D and a drive to improve patient outcomes, Boston Scientific aims to deliver enduring value to healthcare professionals and patients worldwide.
